CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 146 filers reported holding CASTLE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,815 | +23.1% | 1,410 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,345 | -39.6% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $32,035 | -3.5% | 1,410 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $33,191 | -9.7% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $36,773 | +18.8% | 1,410 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $30,950 | -51.1% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $63,253 | -75.3% | 1,410 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $256,148 | -35.5% | 5,975 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $397,338 | -9.3% | 5,975 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $438,147 | +51.4% | 5,975 | +41.4% | 0.01% | +50.0% |
| Q1 2021 | $289,380 | +32.2% | 4,227 | +29.7% | 0.00% | +33.3% |
| Q4 2020 | $218,842 | +30.5% | 3,259 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $167,676 | +36.5% | 3,259 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $122,832 | +26.4% | 3,259 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $97,151 | – | 3,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pembroke Management, LTD | 450,894 | $33,064,000 | 2.59% |
| Monarch Partners Asset Management LLC | 153,887 | $11,285,000 | 1.62% |
| NEXT CENTURY GROWTH INVESTORS LLC | 281,795 | $20,664,000 | 1.61% |
| Mesirow Financial Investment Management, Inc. | 8,183 | $600,000 | 1.53% |
| PERKINS CAPITAL MANAGEMENT INC | 33,150 | $2,431,000 | 1.38% |
| OBERWEIS ASSET MANAGEMENT INC/ | 74,060 | $5,431,000 | 1.19% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 152,474 | $11,181,000 | 1.18% |
| Altium Capital Management LP | 69,000 | $5,060,000 | 1.17% |
| Redwood Investments, LLC | 186,491 | $13,675,000 | 1.10% |
| Lisanti Capital Growth, LLC | 107,650 | $7,894,000 | 0.98% |